Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancerMaria Vittoria Dieci, Valentina Guarneri, Anita Rimanti et al.|Annals of Oncology|2019Cited by 96
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early <i>ERBB2</i>-Positive Breast CancerMaria Vittoria Dieci, Valentina Guarneri, Giancarlo Bisagni et al.|JAMA Oncology|2025Cited by 17
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus projectStefania Gori, Paolo Tralongo, Fiorenza De Rose et al.|Cancer Treatment Reviews|2024Cited by 2
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trialMaria Vittoria Dieci, V Guarneri, Giancarlo Bisagni et al.|ESMO Open|2025Cited by 0